Shawn Fessler Email

Associate Director, Early Phase Discovery Biology . Matchpoint Therapeutics

Current Roles

Employees:
37
Revenue:
$2.9M
About
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines initially focused on immunology. For more information, please visit www.matchpointtx.com.
Matchpoint Therapeutics Address
One Kendall Square
null, null
Matchpoint Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.